跳至主要内容
临床试验/ACTRN12605000014651
ACTRN12605000014651尚未招募不适用

A randomised double blind study of short course systemic steroids versus conventional 14 days course in acute exacerbations of COPD

Tas0 个研究点目标入组 200 人开始时间: 2005年7月18日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
Tas
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
o limit 至 o limit(—)
性别
All

入选标准

  • All patients admitted to the Royal Hobart Hospital with the primary diagnosis of Acute exacerbation of COPD

排除标准

  • 1 Patients who have already received more than one oral CS dose from their GP prior to presentation, or who have received a treatment CS course within the past one-month will not be eligible. 2 Patients on long-term oral CS at a dose of greater than 5 mg/day. 3 Significant co-morbidities such as on-going angina or current cardiac failure 4 Pneumonic consolidation, lung cancer, fibrosis, bronchiectasis or asthma.5 Inability to comply with instructions.6 Patients with inadequate social supports - these patients often have prolonged admissions once the acute phase has resolved ICS begun before admission will not be an exclusion criterion, but will be taken into account in a subgroup analysisexacerbation of COPD

研究者

发起方
Tas

相似试验